EyekareKilitch

Mumbai, India Founded: 2010 • Age: 16 yrs
Manufactures ophthalmic drugs, eye drops, and tablets for vision health in India.

About EyekareKilitch

EyekareKilitch is a Healthcare company based in Mumbai (India) founded in 2010. It manufactures ophthalmic drugs, eye drops, and tablets for vision health in India. It operates on a B2B model. The company has 55 employees. EyekareKilitch offers products and services including Moxieye-PFS, Oxyvision Tablet, GATIEYE-HS, and HALOEYE. Its focus areas include Pharmaceuticals, Medical Innovations, Preservative-Free Technology and Ophthalmology. Its legal entity in India is Eye Kare Kilitch Limited (U24297MH2009PLC198224).

Company details

EyeKare Kilitch is a pharmaceutical company focused on ophthalmology, developing and producing eye care products like drops and tablets using innovative technologies. They operate in-house manufacturing facilities in Mumbai, India, and serve patients nationwide through doctor networks and RD efforts. Their activities emphasize quality compliance and accessibility for optimal vision health.

  • Headquarters Mumbai, India
  • Employees 55
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website eyekarekilitch.com
  • Legal Name Eye Kare Kilitch Limited
  • Date of Incorporation 31 Dec, 2009
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Net Loss
    -₹1.1 Lakh

    FY 2023 · 0% margin

  • EBITDA
    -₹1.1 Lakh

    FY 2023 · 0% margin

  • Employee Count
    55

Products & Services of EyekareKilitch

EyekareKilitch offers a comprehensive portfolio of products and services, including Moxieye-PFS, Oxyvision Tablet, GATIEYE-HS, and HALOEYE.

Moxieye-PFS
Eye Drops

Moxifloxacin solution for treating eye infections

Oxyvision Tablet
Nutritional Supplements

Antioxidant tablet supporting vision health

GATIEYE-HS
Eye Drops

Gatifloxacin drop for ophthalmic conditions

HALOEYE
Eye Drops

Sodium hyaluronate solution for eye lubrication

Board of directors of Eye Kare Kilitch Limited (EyekareKilitch)

Eye Kare Kilitch Limited is the primary company behind EyekareKilitch. The board of Eye Kare Kilitch Limited currently have 6 directors; the longest-serving is Paresh Prataprai Mehta, appointed in 2009. 16 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Paresh Prataprai Mehta
DIN 00148004
Managing Director31 Dec 200916 yrs 10 moEye Kare Kilitch Limited
Mukesh Damji Shah
DIN 00893087
Director30 Jun 201016 yrs 4 moEye Kare Kilitch Limited
Divya Paresh Mehta
DIN 06391672
Director14 May 201313 yrs 6 moEye Kare Kilitch Limited
Neha Paresh Mehta
DIN 00148105
Director14 May 201313 yrs 6 moEye Kare Kilitch Limited
Pradyumna Upendra Pande
DIN 06876992
Director27 May 201412 yrs 5 moEye Kare Kilitch Limited
Mukesh Manmohandas Agashiwala
DIN 06875336
Director01 Dec 201411 yrs 11 moEye Kare Kilitch Limited

Financials of EyekareKilitch

Figures of Eye Kare Kilitch Limited, the primary company behind EyekareKilitch, for FY 2023. Net loss was -₹1.1 Lakh (0% margin). EBITDA was -₹1.1 Lakh (0% margin). Revenue has grown at a compounded annual rate of -100% over five years.

  • -₹1.1 LakhNet loss · 0% margin
  • -₹1.1 LakhEBITDA · 0% margin
  • ₹5.00 CrPaid-up capital
  • 55Employees (provident fund records)
  • -100%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Eye Kare Kilitch Limited are on its company page.

Premium access

Detailed financial statements for EyekareKilitch

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Top companies in Clinical Trials & Research Tech

2 companies that operate in the same segment as EyekareKilitch (Clinical Trials & Research Tech) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
2004Ahmedabad, Gujarat, IndiaUSD 74.68 M1,618
Generic injectables for oncology and anesthesiology are manufactured.
1989Hyderabad, Telangana, IndiaUSD 4.22 M228
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about EyekareKilitch

EyekareKilitch was founded in 2010.

EyekareKilitch is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

EyekareKilitch has 55 employees.

EyeKare Kilitch is a pharmaceutical company focused on ophthalmology, developing and producing eye care products like drops and tablets using innovative technologies. They operate in-house manufacturing facilities in Mumbai, India, and serve patients nationwide through doctor networks and RD efforts. Their activities emphasize quality compliance and accessibility for optimal vision health.

EyekareKilitch offers Moxieye-PFS, Oxyvision Tablet, GATIEYE-HS, and HALOEYE.

EyekareKilitch operates through Eye Kare Kilitch Limited.

The legal entities of EyekareKilitch currently have 6 directors, including Divya Paresh Mehta, Paresh Prataprai Mehta, Mukesh Manmohandas Agashiwala and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available